Cianopramine
Source: Wikipedia, the free encyclopedia.
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
JSmol) | |
|
Cianopramine (
INN) (developmental code name Ro 11-2465), also known as 3-cyanoimipramine, is a tricyclic antidepressant related to imipramine that acts as a serotonin reuptake inhibitor[1] and weak serotonin receptor antagonist.[2][3] It was investigated for the treatment of depression but was never marketed.[3]
See also
References
- S2CID 3112636.
- S2CID 41042435.
- ^ ISBN 978-1-4757-2085-3.
| ||
---|---|---|
SNRIs Tooltip Serotonin–norepinephrine reuptake inhibitors | ||
NRIs Tooltip Norepinephrine reuptake inhibitors | ||
NDRIs Tooltip Norepinephrine–dopamine reuptake inhibitors | ||
NaSSAs Tooltip Noradrenergic and specific serotonergic antidepressants | ||
SARIs Tooltip Serotonin antagonist and reuptake inhibitors | ||
SMS Tooltip Serotonin modulator and stimulators | ||
Others |
|
TCAs Tooltip Tricyclic antidepressants |
| |
---|---|---|
TeCAs Tooltip Tetracyclic antidepressants | ||
Others |
|
|
Miscellaneous | |
---|---|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III